Attached files

file filename
EX-32.2 - EX-32.2 - TETRAPHASE PHARMACEUTICALS INCd847135dex322.htm
EX-31.2 - EX-31.2 - TETRAPHASE PHARMACEUTICALS INCd847135dex312.htm
EX-31.1 - EX-31.1 - TETRAPHASE PHARMACEUTICALS INCd847135dex311.htm
EX-21.1 - EX-21.1 - TETRAPHASE PHARMACEUTICALS INCd847135dex211.htm
EX-32.1 - EX-32.1 - TETRAPHASE PHARMACEUTICALS INCd847135dex321.htm
EX-10.27 - EX-10.27 - TETRAPHASE PHARMACEUTICALS INCd847135dex1027.htm
EX-10.26 - EX-10.26 - TETRAPHASE PHARMACEUTICALS INCd847135dex1026.htm
EXCEL - IDEA: XBRL DOCUMENT - TETRAPHASE PHARMACEUTICALS INCFinancial_Report.xls
10-K - FORM 10-K - TETRAPHASE PHARMACEUTICALS INCd847135d10k.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

 

  (1) Registration Statement (Form S-3 No. 333-195631) of Tetraphase Pharmaceuticals, Inc.
  (2) Registration Statement (Form S-8 No. 333-198098) pertaining to Tetraphase Pharmaceuticals, Inc. 2014 Employee Stock Purchase Plan
  (3) Registration Statement (Form S-8 No. 333-194125) pertaining to the 2013 Stock Incentive Plan of Tetraphase Pharmaceuticals, Inc., and
  (4) Registration Statement (Form S-8 No. 333-189361) pertaining to the 2006 Stock Incentive Plan and the 2013 Stock Incentive Plan of Tetraphase Pharmaceuticals, Inc.,

of our report dated March 6, 2015, with respect to the consolidated financial statements of Tetraphase Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Tetraphase Pharmaceuticals, Inc. for the year ended December 31, 2014.

/s/ Ernst & Young LLP

Boston, Massachusetts

March 6, 2015